Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Experimental Dermatology|September 23, 2008
Evaluation of the role of human herpes virus 6 and 8 in parapsoriasisGaëlle Quéreux, Elisabeth André-Garnier, Anne-Chantal Knol, et al.
European Journal of Dermatology : EJD|March 4, 2017
Impact of the time interval between lymph node recurrence and lymphadenectomy on melanoma patient survivalSophie Vildy, Jean-Michel Nguyen, Aurélie Gaultier, et al.
Expert Opinion on Pharmacotherapy|July 11, 2013
Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literatureGaëlle Quéreux, Melanie Saint-Jean, Lucie Peuvrel, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|February 13, 2015
Tight junction proteins in the canine epidermis: a pilot study on their distribution in normal and in high IgE-producing caninesAnne J J Roussel, Vincent Bruet, Rosanna Marsella, et al.
European Journal of Dermatology : EJD|August 3, 2012
Human β-defensin-2 and psoriasin, two new innate immunity targets of zinc gluconateCarole Poiraud, Gaëlle Quereux, Anne-Chantal Knol, et al.
European Journal of Dermatology : EJD|September 6, 2022
Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinomaCécile Juzot, Anne Isvy-Joubert, Amir Khammari, et al.
International Journal of Dermatology|February 12, 2017
Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanomaRaul E Perret, Nicolas Josselin, Anne-Chantal Knol, et al.
Experimental Dermatology|October 23, 2009
Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexaroteneAnne Chantal Knol, Gaëlle Quéreux, Anabelle Brocard, et al.
Experimental Dermatology|October 23, 2009
About the cutaneous targets of bexarotene in CTCL patientsAnne Chantal Knol, Gaëlle Quéreux, Anabelle Brocard, et al.
European Journal of Dermatology : EJD|June 28, 2016
Immunohistochemical markers of advanced basal cell carcinoma: CD56 is associated with a lack of response to vismodegibJean-Marie Castillo, Anne-Chantal Knol, Jean-Michel Nguyen, et al.
Pageof 5